PREMIERE study: reaching target blood pressure level – a success in coronary heart disease treatment
Aim. To study ACE inhibitor effectiveness and safety in heart failure-free patients with arterial hypertension (AH) and stable coronary heart disease (CHD). Material and methods. Society of Cardiology of the Russian Federation initiated the National Program PREMIERE, focused on ACE inhibitor perindo...
Saved in:
| Main Authors: | Yu. A. Karpov, S. A. Shalnova, A. D. Deev |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2006-12-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1405 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Combined antihypertensive therapy in patients with arterial hypertension and coronary heart disease
by: O. A. Ageenkova, et al.
Published: (2011-06-01) -
Arterial hypertension and coronary heart disease in real-world cardiology practice
by: S. A. Shalnova, et al.
Published: (2006-04-01) -
Clinical and pharmaco-economic assessment of ACE inhibitors perindopril and enalapril in coronary heart disease patients after coronary artery bypass graft surgery
by: Yu. M. Lopatin, et al.
Published: (2009-06-01) -
Endothelial dysfunction and its correction with perindopril therapy in patients with coronary heart disease
by: O. A. Vartanova, et al.
Published: (2008-06-01) -
Perindopril effects on circadian heart rate variability in patients with coronary heart disease and stable angina
by: N. A. Shardanov, et al.
Published: (2007-08-01)